辰欣药业：石四药完成减持452万股，持股降至5.11%

Core Viewpoint - The major shareholder, Shijiazhuang Four Pharmaceutical Co., Ltd., has completed its share reduction plan, which was in line with its previously disclosed intentions [1] Summary by Relevant Sections Shareholder Reduction - Shijiazhuang Four Pharmaceutical Co., Ltd. held 27,661,441 unrestricted circulating shares before the reduction, accounting for 6.11% of the total share capital [1] - The reduction plan was announced on August 30, 2025, with a target to reduce no more than 4,527,000 shares through centralized bidding [1] - As of September 24, 2025, Shijiazhuang Four Pharmaceutical Co., Ltd. had cumulatively reduced 4,520,000 shares, representing 0.998% of the total share capital [1] Financial Details - The share reduction occurred at a price range of 19.70 to 21.17 yuan per share, resulting in a total reduction amount of 91,220,564 yuan [1] - Post-reduction, Shijiazhuang Four Pharmaceutical Co., Ltd. holds 23,141,441 shares, which is 5.11% of the total share capital [1] Compliance with Plan - The reduction was executed as planned and was not terminated early [1]